Andrew Zloza, MD, Ph.D. is a tenure-track Assistant Professor in the Department of Internal Medicine, Division of Hematology, Oncology, and Cell Therapy. Dr. Zloza earned his BS in Chemical Engineering at the Illinois Institute of Technology (IIT) as part of the IIT/Rush University Honors Program in Engineering and Medicine. He completed his MD and Ph.D. (Immunology/Microbiology) studies as part of the Rush Physician Scientist MD Ph.D. Program. He further trained as a Ruth L. Kirschstein National Research Service Award (NRSA) postdoctoral fellow (NIH T32) in Cancer Immunology and Tumor Vaccine Research at The University of Chicago.
Prior to returning to Rush in 2018, Dr. Zloza served as the Section Chief of Surgical Oncology Research and founding Director of the Immune Monitoring Shared Resource at Rutgers Cancer Institute of New Jersey and as a tenure-track Assistant Professor in the Department of Surgery at Rutgers Robert Wood Johnson Medical School.
Current role
Scientific Advisor And Co-founder at Transformative
Managing Partner & Senior Scientific Advisor at Brookline Capital Markets
Chair of the Scientific Advisory Board at Therini Bio, Inc.
Scientific Advisor at zPREDICTA
Co-Founder and Scientific Advisor at Amorphology, Inc
Access the worlds's biggest network of public org charts
Learn more